Sign in

BIOBV on Nasdaq Helsinki Ltd

Biohit

Logo: biohithealthcare.com4

Finnish biotechnology company

Biohit Oyj is a Finnish company which develops, manufactures, and markets biotech and diagnostics products for use in research and health care.2 It was founded by Osmo Suovaniemi.1 Its shares trade on Nasdaq Helsinki Ltd under the symbol BIOBV.1 Wikipedia text CC BY-SA 4.0

Price unavailable

Last updated Oct 21, 2026.

Overview

1988Founded1

Compare with another stock.

  • TickerBIOBV on Nasdaq Helsinki Ltd1
  • Industrybiotechnology industry1
  • HeadquartersHelsinki1
  • Websitewww.biohithealthcare.com/en/home
  • Legal formjulkinen osakeyhtiö1
  • LEI74370089ATTSNBXJVT293
  • StatusActive3
  • LEI statusIssued and current3
  • Registered addressLAIPPATIE 1, FI-00880 Helsinki, Finland3
  • Registered withFinnish Patent and Registration Office, 0703582-03

See how the biggest companies compare on our leaderboards

Biohit Oyj is a Finnish company which develops, manufactures, and markets biotech and diagnostics products for use in research and health care.2

The story

Founded by Osmo Suovaniemi in 1988.1

Leadership

Who has led Biohit, and when. Pick a name to see everywhere that person has worked.

Products and brands

  • medical equipment

Listed on Wikidata.1

Markets

Biohit's two businesses are acetaldehyde-eliminating products and diagnostics. More than 90% of Biohit's sales occur outside Finland.

Diagnostic tests

The diagnostic product range of Biohit includes the GastroPanel examinations, which are used to aid diagnosis of Helicobacter pylori infection and atrophic gastritis from a blood sample. They are also ideal tools for the identification of patients at increased risk of gastric cancer, peptic ulcer disease, gastroesophageal reflux disease (GERD), and deficiencies of vitamin B12, calcium, and iron. In addition to this, Biohit offers Quick tests for the detection of

Lactose intolerance

Helicobacter pylori infection

Read the full text

Celiac disease

Screening of colorectal cancer

Acetaldehyde binding products

In 2018 was launched a new, nicotine-free smoking cessation product, Acetium Lozenge.

Monoclonal antibodies

Biohit also develops and manufactures monoclonal antibodies for research use and use as raw materials for the diagnostic industry.

Instruments

Adopting a systems approach, Biohit also provides laboratory equipment, such as microplate instruments and automates, as well as liquid handling products to support Biohit ELISA tests.

Distribution network

A network of 40 distributors, including 2 subsidiaries, in more than 40 countries is selling Biohit products. In the U.S. the official distributor is Bio Testing Supplies, a division of Avrio Genetics.

Research, development, and intellectual property

Biohit spends roughly 30% of net sales on basic research each year and pursues an aggressive patenting strategy.

From Wikipedia’s article on Biohit, shared under CC BY-SA 4.0.5

Timeline

  1. 1999Went public Listed on Nasdaq Helsinki Ltd1
  2. 1988Founded Founded1

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
    Company websiteBiohit logo
  5. 5